申请人:Benobio Co., Ltd.
公开号:EP4067352A2
公开(公告)日:2022-10-05
The present invention relates to a novel quercetin derivative compound and to a use thereof. More specifically, the present invention relates to a novel quercetin derivative compound having inhibitory activity against bromodomain extra-terminal (BET) proteins, and to a pharmaceutical composition for preventing or treating BET protein-related diseases, comprising the same.
本发明涉及一种新的槲皮素衍生物化合物及其用途。更具体地说,本发明涉及一种新的槲皮素衍生物化合物,具有对溴域额外末端(BET)蛋白的抑制活性,并涉及一种制备用于预防或治疗与BET蛋白相关的疾病的药物组合物。